Elicio Therapeutics Inc.

NASDAQ: ELTX · Real-Time Price · USD
8.06
0.10 (1.26%)
At close: Jun 20, 2025, 2:39 PM

Elicio Therapeutics Revenue

Elicio Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Elicio Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
32
Market Cap
128.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.